Basic HTML Version
www.drinkanddrugs.net
1 March 2010 |
drinkanddrugsnews
| 29
Classified |
Conferences and services
WOMEN AND CHILDREN FIRST ?
Supporting Female Substance Misuser’s and their Families
Brighton Oasis Project
25th May 2010
Audrey Emerton Building, Brighton
Brighton Oasis Project has over 12 years experience delivering community based substance
misuse interventions to women. This conference will bring together speakers from a variety
of disciplines to discuss issues affecting female substance misusers and their children.
The Conference Opening Address will be given by Baroness Doreen Massey, Chair of the
National Treatment Agency.
Aims:
To consider the role of gender specific services, in substance misuse treatment
To consider the evidence around current best practice in safe-guarding the
children of substance misusers
To consider the support needs of the children of substance misusers
To highlight the needs of women substance misusers and identify how these
can be met in practice
Speakers and Workshops Include:
Legal Action to Protect Children Affected by Substance Misusing Mothers:
The Use and Abuse of the Evidence Base, David Spicer, Barrister
Improving the Odds for Substance Misusing Parents and their Children:
Resilience in Action – Professor Angie Hart
A Picture of Family Support – Joss Smith, Adfam
Thresholds in Child Protection – Gretchen Precey, Independent Social Worker
Promoting Understanding and Collaboration to Improve Care and Treatment for
Women with a Dual Diagnosis – Dr Anita Green, Dual Diagnosis Nurse Consultant
The Impact of Maternal Substance Misuse on the Baby – Dr Neil Aiton,
Royal Sussex County Hospital
Not an Occupational Hazard – Sexual Violence & Sex Work - The Harm Reduction
Model - Shelly Stoops, Armistead Street Project
Findings from Local Lesbian, Gay, Bisexual and Trans Research:
Count Me In Too – Dr. Kath Browne
Delegate rate: £120 per person including lunch and refreshments.
For more information, please email info@brightonoasisproject.co.uk
or call 01273 696970 or visit our website:
www.oasisproject.org.uk
LUTON
24hours, 7 days a week care
24 beds quasi – residential primary care – £450
per week
12 week primary care and 12 week secondary care
Detox facilitated
12 Step and holistic therapy
EATA Accredited
Weekly reporting to NDTMS
Block contracts available
Client weekly reports
CHELMSFORD
24 hours, 7 days a week care
24 beds quasi – residential primary care - £495
per week
12 week primary care and 12 week secondary care
Detox facilitated
Luxury Accommodation
12 step and holistic therapy
EATA Accredited
Weekly reporting to NDTMS
Block contracts available
Client weekly reports
DRUG AND ALCOHOL TEAMS, SOCIAL SERVICES
Look no further!
NOWAITING LISTS – IMMEDIATE BEDS AVAILABLE
Email: info@pcpluton.com Web: www.rehabtoday.com
CALL FREE 08000 380 480
PCP spreads the solution to the problem of addiction/alcoholism to
Chelmsford where we are pleased to announce the opening of a new
centre. PCP Chelmsford is fully compliant with the latest quality
standards of performance and employment, QUADs and DANOS, to
ensure all patients receive the best service and treatment.
The Perry Clayman Project was devised to treat drug and alcohol
abuse by incorporating the best of current day abstinence methods.
It is delivered through a Twelve Step structure in four stages of
treatment. Typical treatment spans a minimum of twelve weeks.
The programme is tailored to accommodate the needs of each patient
from initial assessment and detoxification up to graduation.
The Perry Clayman Project is an established consultancy centre
offering all its clients the prospect of a genuine future and the
opportunity to rebuild their lives, move out of the problems of
addiction and into the solution of recovery and sober living.
Conference
Sharps: Best practice in needle
exchange and harm reduction
30th June 2010, London
This conference will bring together
experts in the area of needle exchange
and drug misuse, with speakers from
the National Treatment Agency, Turning
Point Somerset and Project 6, to
discuss best practice and new initiatives.
Challenges for needle exchange
programmes will always appear,
whether they are caused by new
drugs, changes in injecting habits, or
different clients. All these possibilities
need to be considered and assessed
and the conference will discuss
solutions and future initiatives, such as
the advantages and disadvantages of
assisted injecting rooms.
For more information and a booking
form please contact Jennifer Tatman
on +44 (0)20 3177 1614 or
jtatman@rsph.org.uk
www.rsph.org.uk